2024-07-06 16:15:54
From Paraná to the world: Biogénesis Bagó becomes the largest producer of veterinary vaccines in Latin America with the opening of its factory in Brazil
Biogénesis Bagó, a leading global biotechnology company in the animal health, productivity and welfare sector, strengthens its leadership in Latin America by opening a veterinary vaccine production plant in Campo Largo (PR).
After 25 years of presence in Brazil, Biogénesis Bagó begins its first industrial operation in the country following the highest quality standards, in which it will develop and produce biotechnological solutions aimed mainly at the fastest growing segment in the veterinary industry: companion animals.
New veterinary vaccine factory in Campo Largo (PR) will produce more than 10 million doses of vaccines for companion and production animals
The Campo Largo factory will specialize in the development and production of animal health solutions for multiple species, with the highest global certifications for quality and scientific innovation.
With an annual production capacity of more than 10 million doses of vaccines, the new factory will position Biogénesis Bagó as the leading company in Latin America in terms of production capacity for companion animals and one of the ten largest players in animal health in the world.
Initially, the plant will focus on the production of three vaccines for companion animals: the triple feline vaccine and the quintuple/sextuple vaccine with and without leptospira. In addition, the production of three other vaccines for farm animals and other biotechnological solutions is planned. This portfolio will allow Biogénesis Bagó to expand into new markets and consolidate itself as a full-fledged player in animal health.
Marcelo Bulman – Photo release
R$ 100 million in investments in the veterinary vaccine factory
With over R$100 million in investments, the new veterinary vaccine factory in Campo Largo (PR) will feature state-of-the-art technological equipment for the production of live attenuated biological vaccines. With a total constructed area of 4,000 square meters, the factory will also be a technological center for the production, research and development of new products. In addition, it will serve as a logistics distributor for the region. The Campo Largo factory will generate over 300 direct and indirect jobs in total, being one of the factories with the most advanced technology for the production of chewable tablets and live attenuated vaccines in Latin America.
“This investment will allow us to expand our production capacity and strengthen our complete portfolio of companion and production animals. It will also give us the opportunity to reach new markets, taking Biogénesis Bagó’s presence to every corner of the world,” highlights the company’s Country Manager in Brazil, Marcelo Bulman.
With this new production hub in Brazil, Biogénesis Bagó expands its industrial presence, joining industrial plants in Saudi Arabia, China and South Korea. This initiative, combined with the solid experience in Argentina, consolidates Biogénesis Bagó as a global reference in animal health solutions, supplying the main international markets.
The inauguration of the new Biogénesis Bagó factory in Campo Largo, Paraná, marks the beginning of a new stage for the company in the animal health market in Brazil, as well as in Latin America and the world.
About Biogenesis Bagó
Biogénesis Bagó is a leading global biotechnology company in the animal health, productivity and welfare sector. It develops, produces and markets world-class products to protect the health status of countries and plays a key role in the prevention of zoonoses and the safety of food production. It is a reference in the prevention and control of foot-and-mouth disease and one of the main producers of canine and feline rabies vaccines, being able to respond immediately to health emergencies anywhere in the world.
1720284790
#Biogénesis #Bagó #veterinary #vaccines #manufactured #Brazil